Chem. J. Chinese Universities ›› 2015, Vol. 36 ›› Issue (12): 2582.doi: 10.7503/cjcu20150551

• Polymer Chemistry • Previous Articles     Next Articles

Fabrication and Characterization of PLGA-based Supermolecular Hydrogel

LI Guifei, WU Jie, WANG Bo, ZHANG Weijun, YAN Shifeng, YIN Jingbo*()   

  1. Department of Polymer Materials, School of Materials Science and Engineering,Shanghai University, Shanghai 200444, China
  • Received:2015-07-14 Online:2015-12-10 Published:2015-10-12
  • Contact: YIN Jingbo E-mail:jbyin@oa.shu.edu.cn
  • Supported by:
    † Supported by the National Natural Science Foundation of China(Nos.51373094, 51173101, 51473090), the Science and Technology Commission of Shanghai Municipality, China(No.15JC1490400) and the Youth Teacher Training Program of Shanghai University, China

Abstract:

Supermolecular hydrogels composed of cholesterol-modified triblock polymers poly(L-glutamic acid)-poly(ethylene glycol)-poly(L-glutamic acid)[(PLGA-b-PEG-b-PLGA)-g-Chol] and β-cyclodextrins(β-CD)-modified poly(L-glutamic acid)(PLGA-g-β-CD) were fabricated by host-guest interaction between cholesterol(Chol) and β-CD. This study presented the influence of concentrations and molar ratio on mechanical strength, PLGA molecular weight on mechanical strength, pore size, swelling ratios and biodegradability. The results showed that storage modulus was highest at concentrations of 150 g/L and Chol/β-CD molar ratio of 1:1. The average pore size of PLGA-based supermolecular hydrogels fabricated from concentrations of 150 g/L was between 10—30 μm. Swelling ratio was between 16%—32.5%. Degradation time could be controlled PLGA molecular weight from 40 d to 72 d. The excellent self-healing ability of hydrogels was performed. The cytotoxicity evaluation was observed that the adipose-derived stem cells treated with the polymers remained almost 100% viable, indicating good cytocompatibility of the hydrogels.

Key words: Poly(L-glutamic acid), β-Cyclodextrin, Cholesterol, Supermolecular hydrogel, Storage modulus, Cytocompatibility

CLC Number: 

TrendMD: